Czech stem-cell work heightens calls for EU ruling

The Eu Stem Cell Debate: Can Patenting Stem Cell Innovations

issued a preliminary and non-binding guidance opinion (‘the Opinion’) in the Court of Justice of the European Union (‘the CJEU’) Case C-34/10 Professor Dr Oliver Brüstle v Greenpeace eV, which has provoked numerous responses from both sides of the embryonic stem cell patenting debate. Oral proceedings took place at the CJEU in Luxembourg on 11 January 2011, before the entire Grand Chamber of 13...

Hematopoietic Stem Cell Transplantation for Thalassemia

Thalassemia is an autosomal recessive disorder associated with defective synthesis of the α- or β-chain of hemoglobin. For β-thalassemia major patients, therapeutic options are either monthly red cell transfusions and chelation therapy or allogeneic stem cell transplant. Stem cell transplant is the only curative approach and success is inversely correlated with the degree of iron overload and h...

Looking for immortality: Review of phytotherapy for stem cell senescence

Objective(s): In this paper, we discussed natural agents with protective effects against stem cell senescence. Different complications have been observed due to stem cell senescence and the most important of them is “Aging”. Senescent cells have not normal function and their secretary inflammatory factors induce chronic inflammation in body which causes different patho...

In-work poverty in the EU

P11: From Well to Bed: Stem Cell Therapies for Neurotrauma

لطفاً به چکیده انگلیسی مراجعه شود.